Comparison of the efficacies of amantadine treatment of swine-origin influenza virus A H1N1 and seasonal influenza H1N1 and H3N2 in Japan (2008-2009)

Journal of Infection and Chemotherapy

Volumn 17, Issue 4, 2011, Pages 524-529

  Miyachi, Kiyomitsu ^a   Watanabe, Atushi ^b   Iida, Hiromasa ^c   Hattori, Haruki ^d   Ukai, Hiroshi ^e   Takano, Tsuruyo ^f   Hankins, Raleigh W ^g  

^a Keigu Clinic   (Japan)

^b Asunaro Pharmacy   (Japan)

^c Iida Clinic   (Japan)

^d Hattori Clinic   (Japan)

^e Ukai Clinic   (Japan)

^f Yokohama Institute for Hygiene   (Japan)

^g Health Sciences Research Institute Inc   (Japan)

Author keywords

Amantadine; Amantadine resistance; M2 protein; Oseltamivir; Swine origin influenza virus (S OIV); Zanamivir

Indexed keywords

AMANTADINE; OSELTAMIVIR; PROTEIN M2; ZANAMIVIR;

ADOLESCENT; ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; BEHAVIOR DISORDER; BODY TEMPERATURE; CHILD; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DNA DETERMINATION; DRUG EFFICACY; DRUG RESPONSE; GENE MUTATION; HUMAN; INFANT; INFLUENZA A (H1N1); INFLUENZA A (H3N2); JAPAN; M2 GENE; MAJOR CLINICAL STUDY; NAUSEA AND VOMITING; PRESCHOOL CHILD; SCHOOL CHILD; SEASONAL INFLUENZA; SPUTUM ANALYSIS; TREATMENT DURATION; VIRUS GENE; VISUAL DISORDER;

EID: 80052858895     PISSN: 1341321X     EISSN: 14377780     Source Type: Journal    
DOI: 10.1007/s10156-011-0217-2     Document Type: Article

References (16)

1. Centers for Disease Control, Prevention (CDC). Outbreak of swine-origin influenza A (H1N1) virus infection-Mexico, March-April 2009. JAMA. 2009;58:467-70.
2. Centers for Disease Control and Prevention (CDC). Swine-origin influenza A (H1N1) virus infections in a school-New York City. MMWR. 2009;8(58):470-2.
3. SB Mossad 2009 The resurgence of swine-origin influenza A (H1N1) Cleve Clin J Med. 76 337 343 19487554 10.3949/ccjm.76a.09047
4. FS Dawood S Jain L Finelli MW Shaw S Lindstrom RJ Garten, et al. 2009 Emergence of a novel swine-origin influenza A (H1N1) virus in humans N Engl J Med 360 2605 2615 19423869 10.1056/NEJMoa0903810
5. Centers for Disease Control and Prevention (CDC) 2009 Update: drug susceptibility of swine-origin influenza A (H1N1) viruses MMWR 58 433 435
6. N Kawai H Ikematsu N Iwaki I Satoh T Kawashima K Miyachi, et al. 2005 Factors influencing the effectiveness of oseltamivir and amantadine for the treatment of influenza: a multicenter study from Japan of the 2002-2003 influenza season Clin Infect Dis 40 1309 1316 15825034 10.1086/429241 1:CAS:528:DC%2BD2MXktlajsrw%3D (Pubitemid 40570241)
7. RA Bright DK Shay B Shu NJ Cox AI Klimov 2006 Amantadine resistance among influenza A during the 2005-2006 influenza season in the United State JAMA 295 891 894 16456087 10.1001/jama.295.8.joc60020 1:CAS:528:DC%2BD28Xhs1Ckur0%3D
8. N Kawai H Ikematsu N Iwai K Kawamura T Kawashima S Kashiwagi 2007 A change in the effectiveness of amantadine for the treatment of influenza over the 2003-2004, 2004-2005, and 2005-2006 influenza seasons in Japan J Infect Chemother 13 314 319 17982720 10.1007/s10156-007-0538-3 1:CAS:528: DC%2BD2sXht1Glu7rO (Pubitemid 350059916)
9. AL Hersh JH Maselli M Cabana 2009 Changes in prescribing of antiviral medications for Influenza associated with new treatment guidelines Am J Public Health 99 Suppl 2 362 364 10.2105/AJPH.2009.171462
10. WY Choi S Kim N Lee M Kwon I Yang MJ Kim, et al. 2009 Amantadine-resistant influenza A viruses isolated in South Korea from 2003 to 2009 Antiviral Res 84 199 202 19720085 10.1016/j.antiviral.2009.08.006 1:CAS:528:DC%2BD1MXht1WrsbzJ
11. Y Furuse A Suzuki M Shimizu M Kishi R Sawayama M Saito, et al. 2009 Reassortment between amantadine-resistant and -sensitive H1N1 influenza A viruses generated an amantadine-sensitive virus during the 2007-2008 season J Infect Dis 200 1766 1773 19874176 10.1086/647989
12. Baranovich T, Saito R, Suzuki Y, Zaraket H, Depat C, Caperig-Dapat I, et al. Emergence of H274Y oseltamivir-resistant A (H1N1) influenza viruses in Japan during the 2008-2009 season. J clin Virol. 2010;47:23-8.
13. Suzuki H, Saito R, Masuda H, Sato M, Sato I. Emergence of amantadine-resistant influenza A viruses: epidemiological study. J Infect Chemother. 2003;9:195-200. (Pubitemid 37288281)
14. X Jing C Ma Y Ohigashi FA Oliveira TS Jardetky LH Pinto, et al. 2008 Functional studies indicate amantadine binds to the pore of influenza virus M2 proton selective ion channel Proc Natl Sci Acad USA 105 10967 10972 10.1073/pnas.0804958105 1:CAS:528:DC%2BD1cXpvFOis7Y%3D
15. K Shiraishi K Mitamura Y Sakai-Tagawa H Goto N Sugaya Y Kawaoka 2003 High frequency of resistant viruses harboring different mutation in amantadine-treated children with influenza J Infect Dis 188 57 61 12825171 10.1086/375799 (Pubitemid 36829742)
16. J Burch M Paulden S Conti C Stock M Corbett NJ Welton, et al. 2009 Antiviral drugs for the treatment of influenza: a systematic review and economic evaluation Health Technol Assess 13 1 285 19954682 1:STN:280: DC%2BD1MjpvVSisA%3D%3D, iii-iv